SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21487429
Source:
http://linkedlifedata.com/resource/pubmed/id/21487429
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0029925
,
umls-concept:C0041904
,
umls-concept:C0162638
,
umls-concept:C0667830
,
umls-concept:C1518174
pubmed:issue
8
pubmed:dateCreated
2011-4-13
pubmed:abstractText
Drug resistance is a major problem in ovarian cancer. Triggering apoptosis using death ligands such as tumour necrosis factor-related apoptosis inducing ligand (TRAIL) might overcome chemoresistance.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0370635
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 8
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/TNF-Related Apoptosis-Inducing...
,
http://linkedlifedata.com/resource/pubmed/chemical/TNFSF10 protein, human
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1532-1827
pubmed:author
pubmed-author:DuikerE WEW
,
pubmed-author:ImaiH THT
,
pubmed-author:MeersmaG JGJ
,
pubmed-author:MeijerAA
,
pubmed-author:de JongSS
,
pubmed-author:de VriesE GEG
,
pubmed-author:van der BiltA R MAR
,
pubmed-author:van der ZeeA G JAG
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1278-87
pubmed:meshHeading
pubmed-meshheading:21487429-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:21487429-Apoptosis
,
pubmed-meshheading:21487429-Carcinoma
,
pubmed-meshheading:21487429-Caspase 8
,
pubmed-meshheading:21487429-Cell Line, Tumor
,
pubmed-meshheading:21487429-Cisplatin
,
pubmed-meshheading:21487429-Drug Evaluation, Preclinical
,
pubmed-meshheading:21487429-Drug Resistance, Neoplasm
,
pubmed-meshheading:21487429-Female
,
pubmed-meshheading:21487429-Gene Expression Regulation, Enzymologic
,
pubmed-meshheading:21487429-Gene Expression Regulation, Neoplastic
,
pubmed-meshheading:21487429-Humans
,
pubmed-meshheading:21487429-Ovarian Neoplasms
,
pubmed-meshheading:21487429-Recombinant Proteins
,
pubmed-meshheading:21487429-TNF-Related Apoptosis-Inducing Ligand
,
pubmed-meshheading:21487429-Up-Regulation
pubmed:year
2011
pubmed:articleTitle
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.
pubmed:affiliation
Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't